BTC Health (BTC) 2019年年度报告「ASX」.pdf

1、 BTC HEALTH|ANNUAL REPORT PG 0 BTC HEALTH|ANNUAL REPORT PG 1 2 17 42 4 40 46 11 41 48 Chairmans Letter Directors Report Corporate Governance Statement Financial Report Directors Declaration Auditors Independence Declaration Independent Auditor Report Shareholder Information Corporate Directory Conte

2、nts BTC HEALTH|ANNUAL REPORT PG 2 Chairmans letter Last year we changed the company name to BTC health in order to more effectively communicate the strategic intent of the group and to position the business as a provider of innovative pharmaceutical products and medical devices.We believe that the c

3、ombined factors of an ageing population,increased healthcare expenditure,new technologies and the constant striving for better health outcomes makes this a particularly exciting and relevant space in which to invest and build.BTC health has a vision to become a leading supplier of innovative medical

4、 products in Australia and New Zealand and our team is motivated by the opportunity to provide patients with greater access to some of the best specialised therapeutics and medical devices from around the world I am pleased to report that in the last 12-months we have taken decisive steps toward bui

5、lding BTC health as a group of high-growth businesses in the healthcare space.On 31 May 2019,BTC Speciality Health acquired the hospital infusion business from Admedus Australia for a purchase price of$6.3m.The acquisition included$1.75m of working capital,the novation of an 8-year agreement for the

6、 exclusive distribution rights for the ambIT infusion pumps in Australia and New Zealand,as well as the transfer of ten experienced hospital sales personnel and an established customer base.We recognised the ambIT infusion pumps to be high quality devices with good growth potential in both the priva